Author:
Cama Jehangir,Al Nahas Kareem,Fletcher Marcus,Hammond Katharine,Ryadnov Maxim G.,Keyser Ulrich F.,Pagliara Stefano
Abstract
AbstractAntimicrobial resistance challenges the ability of modern medicine to contain infections. Given the dire need for new antimicrobials, polypeptide antibiotics hold particular promise. These agents hit multiple targets in bacteria starting with their most exposed regions—their membranes. However, suitable approaches to quantify the efficacy of polypeptide antibiotics at the membrane and cellular level have been lacking. Here, we employ two complementary microfluidic platforms to probe the structure–activity relationships of two experimental series of polypeptide antibiotics. We reveal strong correlations between each peptide’s physicochemical activity at the membrane level and biological activity at the cellular level. We achieve this knowledge by assaying the membranolytic activities of the compounds on hundreds of individual giant lipid vesicles, and by quantifying phenotypic responses within clonal bacterial populations with single-cell resolution. Our strategy proved capable of detecting differential responses for peptides with single amino acid substitutions between them, and can accelerate the rational design and development of peptide antimicrobials.
Funder
Wellcome Trust
Winton Programme for the Physics of Sustainability
Cambridge-NPL studentship
Trinity-Henry Barlow Scholarship
Engineering and Physical Sciences Research Council
Innovate UK
Department for Business, Energy and Industrial Strategy, UK Government
European Research Council
Medical Research Council
Biotechnology and Biological Sciences Research Council
Royal Society
Gordon and Betty Moore Foundation
H2020 Marie Skłodowska-Curie Actions
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. (2016).
2. World Bank. Drug-Resistant Infections: A Threat to Our Economic Future. https://doi.org/10.1007/s11947-009-0181-3 (2017).
3. Wellcome. The Global Response to AMR: Momentum, Success, and Critical Gaps (2020).
4. Cama, J., Henney, A. M. & Winterhalter, M. Breaching the barrier: Quantifying antibiotic permeability across gram-negative bacterial membranes. J. Mol. Biol. 431(18), 3531–3546 (2019).
5. Cama, J. et al. To push or to pull? In a post-COVID world, supporting and incentivizing antimicrobial drug development must become a governmental priority. ACS Infect. Dis. 7(8), 2029–2042 (2021).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献